There are substantial developments around
MetLife (MET), with a series of important announcements, movements, and operations. MET has received a
buy recommendation from Bank of America Securities and a price target increase from Wells Fargo. Notably, MET's new MIM Segment and Capital Return scheme have been keenly followed in the market. Despite shares being sold by various institutions like Bogart Wealth LLC, Sumitomo Mitsui Trust Group, and Robeco Institutional Asset Management, other entities like Nordea Investment Management, First Horizon Corp, and Oregon Public Employees Retirement Fund have increased their holdings. MetLife's overall market expectations are still considerably strong, with the company's recent acquisition of PineBridge Investments and periodic dividend declarations. However, MET missed its Q3 sales expectations and Q2 Revenue estimates, experiencing a drop in stock price. Its $10 billion variable annuity risk transfer transaction, share buybacks, and the reshaping of its core investment narrative via new initiatives are actions closely watched by investors. Finally, there have been some criticisms and concerns voiced about MET's performance relative to the rest of the financial sector, which might bring some caution to investors.
Metlife MET News Analytics from Mon, 31 Mar 2025 07:00:00 GMT to Sat, 17 Jan 2026 14:01:04 GMT -
Rating 7
- Innovation 6
- Information 8
- Rumor -4
